EverSource Wealth Advisors
GLSI icon

EverSource Wealth Advisors’s Greenwich LifeSciences GLSI Stock Holding History

EverSource Wealth Advisors’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117 Sell
5
-3
-38% -$73 ﹤0.01% 4294
2026
Q1 		$192 Buy
8
+3
+60% +$78 ﹤0.01% 4203
2025
Q4 		$105 Sell
5
-27
-84% -$284 ﹤0.01% 4093
2025
Q3 		$318 Hold
32
– – ﹤0.01% 4044
2025
Q2 		$290 Buy
32
+29
+967% +$276 ﹤0.01% 4007
2025
Q1 		$29 Buy
+3
New +$36 ﹤0.01% 3946

Other funds holding GLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

EverSource Wealth Advisors's GLSI Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Greenwich LifeSciences (GLSI) stake by 38% in Q2 2026, selling an estimated $73 and leaving 5 shares worth $117. The position accounts for ﹤0.01% of the portfolio, ranked #4294.

EverSource Wealth Advisors first reported a position in GLSI in Q1 2025 and has held it in 6 quarters since. The position peaked at $318 in Q3 2025. 57 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

  • EverSource Wealth Advisors held 5 shares of Greenwich LifeSciences worth $117 as of Q2 2026.
  • EverSource Wealth Advisors sold 3 Greenwich LifeSciences shares in Q2 2026, an estimated $73.
  • Greenwich LifeSciences made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #4294 holding.
  • EverSource Wealth Advisors first reported a position in Greenwich LifeSciences in Q1 2025 and has held it in 6 quarters since.
  • EverSource Wealth Advisors's Greenwich LifeSciences position peaked at $318 in Q3 2025.
  • 57 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.